Jeremy L. Freeman

12.2k total citations
223 papers, 7.8k citations indexed

About

Jeremy L. Freeman is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Jeremy L. Freeman has authored 223 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Surgery, 76 papers in Endocrinology, Diabetes and Metabolism and 50 papers in Oncology. Recurrent topics in Jeremy L. Freeman's work include Thyroid Cancer Diagnosis and Treatment (76 papers), Thyroid and Parathyroid Surgery (41 papers) and Head and Neck Cancer Studies (30 papers). Jeremy L. Freeman is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (76 papers), Thyroid and Parathyroid Surgery (41 papers) and Head and Neck Cancer Studies (30 papers). Jeremy L. Freeman collaborates with scholars based in Canada, Australia and United States. Jeremy L. Freeman's co-authors include L. Sylvia, Shereen Ezzat, Ian Witterick, Irving B. Rosen, A. Simon Harvey, Paul G. Walfish, Spiro Eski, Patrick Gullane, Mark L. C. Khoo and Jonathan C. Irish and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jeremy L. Freeman

217 papers receiving 7.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeremy L. Freeman Canada	51	3.2k	3.1k	1.7k	1.1k	990	223	7.8k
Keigo Endo Japan	55	1.9k 0.6×	1.5k 0.5×	1.4k 0.8×	1.4k 1.3×	352 0.4×	338	9.5k
Charles A. Sklar United States	81	2.3k 0.7×	2.8k 0.9×	4.0k 2.3×	2.9k 2.6×	1.0k 1.0×	274	24.2k
Marcel P. M. Stokkel Netherlands	44	1.9k 0.6×	1.8k 0.6×	1.1k 0.6×	572 0.5×	276 0.3×	243	7.6k
William B. Farrar United States	43	1.3k 0.4×	482 0.2×	2.6k 1.5×	490 0.4×	965 1.0×	89	6.9k
I. Ross McDougall United States	36	1.4k 0.4×	3.3k 1.0×	572 0.3×	439 0.4×	368 0.4×	150	5.6k
Dana M. Hartl France	45	4.1k 1.3×	4.2k 1.3×	1.5k 0.9×	795 0.7×	641 0.6×	178	8.3k
Martin J. Black Canada	36	1.6k 0.5×	854 0.3×	1.2k 0.7×	531 0.5×	202 0.2×	134	4.0k
Rodney H. Reznek United Kingdom	56	3.9k 1.2×	2.0k 0.6×	1.2k 0.7×	369 0.3×	160 0.2×	176	8.6k
Rena Vassilopoulou‐Sellin United States	43	2.0k 0.6×	2.6k 0.8×	1.5k 0.8×	503 0.5×	913 0.9×	145	5.4k
G. Brandon Gunn United States	45	1.9k 0.6×	997 0.3×	1.8k 1.0×	462 0.4×	322 0.3×	288	6.8k

Countries citing papers authored by Jeremy L. Freeman

Since Specialization

Citations

This map shows the geographic impact of Jeremy L. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy L. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy L. Freeman more than expected).

Fields of papers citing papers by Jeremy L. Freeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy L. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy L. Freeman. The network helps show where Jeremy L. Freeman may publish in the future.

Co-authorship network of co-authors of Jeremy L. Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy L. Freeman. A scholar is included among the top collaborators of Jeremy L. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy L. Freeman. Jeremy L. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kooiker, Kristina B., Christian Mandrycky, Jeremy L. Freeman, et al.. (2023). The biochemically defined super relaxed state of myosin—A paradox. Journal of Biological Chemistry. 300(1). 105565–105565. 15 indexed citations

Bennett, Mark F., Ilka Immisch, Jeremy L. Freeman, et al.. (2023). Mosaic variants detectable in blood extend the clinicogenetic spectrum of GLI3-related hypothalamic hamartoma. SHILAP Revista de lepidopterología. 1(1). 100810–100810. 2 indexed citations

Chen, Kuizhi, et al.. (2017). Direct Detection of Multiple Acidic Proton Sites in Zeolite HZSM-5. Journal of the American Chemical Society. 139(51). 18698–18704. 80 indexed citations

Ralhan, Ranju, Akram Alyass, Christina MacMillan, et al.. (2015). Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application. Thyroid. 25(11). 1224–1234. 9 indexed citations

Freeman, Jeremy L. & Gary Marcus. (2015). The Future of the Brain. Princeton University Press eBooks. 13 indexed citations

Prisman, Eitan, Eitan Prisman, Eliezer Z. Prisman, Eliezer Z. Prisman, & Jeremy L. Freeman. (2013). Intraoperative risk management of hyperparathyroidism: Modeling and testing the parathyroid hormone’s evolution as a mean reverting stochastic processes. Operations Research for Health Care. 3(1). 7–14.

Mohamed, Ahmad Rithauddin, Catherine Bailey, Jeremy L. Freeman, et al.. (2012). Intrinsic epileptogenicity of cortical tubers revealed by intracranial EEG monitoring. Neurology. 79(23). 2249–2257. 59 indexed citations

Sawka, Anna M., Sharon E. Straus, Lorne Rotstein, et al.. (2012). Randomized Controlled Trial of a Computerized Decision Aid on Adjuvant Radioactive Iodine Treatment for Patients With Early-Stage Papillary Thyroid Cancer. Journal of Clinical Oncology. 30(23). 2906–2911. 37 indexed citations

Kashat, Lawrence, Tada Kunavisarut, Dae Hyun Kim, et al.. (2012). An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma. PLoS ONE. 7(9). e42893–e42893. 16 indexed citations

10.

Shah, Manish D., et al.. (2010). Thyroid Cancer Outcomes in Filipino Patients. Archives of Otolaryngology - Head and Neck Surgery. 136(2). 138–138. 30 indexed citations

11.

Ralhan, Ranju, Anthony K.-C. So, S. C. Tripathi, et al.. (2010). Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers. PLoS ONE. 5(11). e14130–e14130. 36 indexed citations

12.

Payne, Richard J., et al.. (2009). Prognostic Factors in Patients with Multiple Recurrences of Well-Differentiated Thyroid Carcinoma. Journal of Oncology. 2009. 1–6. 7 indexed citations

13.

Fields, Paul, G. Mikhaeel, Jeremy L. Freeman, et al.. (2003). Diffuse large B cell lymphoma: Characterisation of immunohistochemical and interim PET scan analysis and correlation with outcome.. Blood. 102(11). 1 indexed citations

14.

Khoo, Mark L. C., Nigel Beasley, Shereen Ezzat, Jeremy L. Freeman, & L. Sylvia. (2002). Overexpression of Cyclin D1 and Underexpression of p27 Predict Lymph Node Metastases in Papillary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 87(4). 1814–1818. 118 indexed citations

15.

Khoo, Mark L. C., Shereen Ezzat, Jeremy L. Freeman, & L. Sylvia. (2002). Cyclin D1 Protein Expression Predicts Metastatic Behavior in Thyroid Papillary Microcarcinomas But Is Not Associated with Gene Amplification. The Journal of Clinical Endocrinology & Metabolism. 87(4). 1810–1813. 76 indexed citations

16.

Ezzat, Shereen, et al.. (1996). Prevalence of Activating ras Mutations in Morphologically Characterized Thyroid Nodules. Thyroid. 6(5). 409–416. 79 indexed citations

17.

Sugg, Sonia L., Lishu Zheng, Irving B. Rosen, et al.. (1996). ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?. The Journal of Clinical Endocrinology & Metabolism. 81(9). 3360–3365. 119 indexed citations

18.

Hoşal, Melek Banu, Şefik Hoşal, Jeffrey J. Hurwitz, & Jeremy L. Freeman. (1995). A Rationale for the Selection of Nasal Decongestants in Lacrimal Drainage Surgery. Ophthalmic Plastic and Reconstructive Surgery. 11(3). 215–220. 9 indexed citations

19.

Fliss, Dan M., Jay R. Parikh, & Jeremy L. Freeman. (1992). AIDS-related Kaposi's sarcoma of the sphenoid sinus.. PubMed. 21(4). 235–7. 8 indexed citations

20.

Freeman, Jeremy L., et al.. (1984). Retrospective review of 242 consecutive patients treated surgically for parotid gland tumours.. PubMed. 37(3). 340–6. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact